Safety and clinical activity of BMS-986365 (CC-94676), a dual androgen receptor ligand-directed degrader and antagonist, in heavily pretreated patients with metastatic castration-resistant prostate cancer ☆
Titel:
Safety and clinical activity of BMS-986365 (CC-94676), a dual androgen receptor ligand-directed degrader and antagonist, in heavily pretreated patients with metastatic castration-resistant prostate cancer ☆
Auteur:
Rathkopf, D.E. Patel, M.R. Choudhury, A.D. Rasco, D. Lakhani, N. Hawley, J.E. Srinivas, S. Aparicio, A. Narayan, V. Runcie, K.D. Emamekhoo, H. Reichert, Z.R. Nguyen, M.H. Wells, A.L. Kandimalla, R. Liu, C. Suryawanshi, S. Han, J. Wu, J. Arora, V.K. Pourdehnad, M. Armstrong, A.J.